Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Soner Altiok"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/d254f0cf03614cf4a2c1da5abc81e447
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/6111a677811f4519bfcbd0eb21cae6dc
Autor:
Jared Ehrhart, Soner Altiok, Brittany Bunch, Kelly Guzman, Autumn Joerger, Nino Mtchedlidze, Olivia Hoff
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/402ae7d3767a4210a140536d98711616
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/a891666709bf46d89e0ca52b00b2eaad
Autor:
Angela Babetski Holton, Francy L Sinatra, Jenny Kreahling, Amy J Conway, David A Landis, Soner Altiok
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169797 (2017)
The tumor microenvironment is composed of cellular and stromal components such as tumor cells, mesenchymal cells, immune cells, cancer associated fibroblasts and the supporting extracellular matrix. The tumor microenvironment provides crucial support
Externí odkaz:
https://doaj.org/article/c7e0a0050aad42d39c02be709bb97767
Autor:
Jenny M Kreahling, Parastou Foroutan, Damon Reed, Gary Martinez, Tiffany Razabdouski, Marilyn M Bui, Meera Raghavan, Douglas Letson, Robert J Gillies, Soner Altiok
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e57523 (2013)
Sarcomas are rare and heterogeneous mesenchymal tumors affecting both pediatric and adult populations with more than 70 recognized histologies. Doxorubicin and ifosfamide have been the main course of therapy for treatment of sarcomas; however, the re
Externí odkaz:
https://doaj.org/article/9ede9ec3acd24f63b90aa0a120503561
Autor:
Parastou Foroutan, Jenny M Kreahling, David L Morse, Olya Grove, Mark C Lloyd, Damon Reed, Meera Raghavan, Soner Altiok, Gary V Martinez, Robert J Gillies
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e82875 (2013)
Combinations of targeted drugs have been employed to treat sarcomas, however, response rates have not improved notably, therefore emphasizing the need for novel treatments. In addition, imaging approaches to assess therapeutic response is lacking, as
Externí odkaz:
https://doaj.org/article/2f7d618fe882444ab7a3ddba9fac5cfc
Autor:
William Brazelle, Jenny M Kreahling, Jennifer Gemmer, Yihong Ma, W Douglas Cress, Eric Haura, Soner Altiok
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e14335 (2010)
Histone deacetylase inhibitors (HDACis) are promising anticancer drugs; however, the molecular mechanisms leading to HDACi-induced cell death have not been well understood and no clear mechanism of resistance has been elucidated to explain limited ef
Externí odkaz:
https://doaj.org/article/ed8466ef2cf6460499e950aaf3688520
Autor:
Victor, Zota, Gene P, Siegal, David, Kelly, Julia A, Bridge, Anders, Berglund, Katherine, Bui, Farah, Khalil, Damon, R Reed, Soner, Altiok, Anthony, Magliocco, Marilyn M, Bui
Publikováno v:
Fetal and Pediatric Pathology. 42:241-252
Autor:
Manuel Hidalgo, Anirban Maitra, Ralph H. Hruban, James Eshleman, Wells Messersmith, Charles Yeo, Piotr Kulesza, Soner Altiok, Maria L. Amador, Nadia Bouraoud, Hossein Salimi-Moosavi, Sharat Singh, Koji Tanaka, Hidekazu Kuramochi, Peter V. Danenberg, Kathleen Danenberg, Chanjusn Shi, Collins Karikari, Christine Iacobuzio-Donahue, Xianfeng Zhang, George Cusatis, Antonio Jimeno, Belen Rubio-Viqueira
Supplementary Table 1 from An In vivo Platform for Translational Drug Development in Pancreatic Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::943fec57a1fd875cd2d0499551e88cdc
https://doi.org/10.1158/1078-0432.22441180.v1
https://doi.org/10.1158/1078-0432.22441180.v1